West Africa Ebola trials to test brincidofovir, favipiravir
This article was originally published in Scrip
Executive Summary
Trials testing Fujifilm's and MediVector's favipiravir (T-705) and Chimerix's brincidofovir (CMX001) as treatments for Ebola will get underway in West Africa next month, said the international humanitarian medical group Médecins Sans Frontières (MSF)/Doctors Without Borders, which is hosting the studies.